Cargando…

Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review

The von Hippel-Lindau (VHL) gene is often inactivated in sporadic renal cell carcinoma (RCC) by mutation or promoter hypermethylation. The prognostic or predictive value of VHL gene alteration is not well established. We conducted this meta-analysis to evaluate the association between the VHL altera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Bum Jun, Kim, Jung Han, Kim, Hyeong Su, Zang, Dae Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355155/ https://www.ncbi.nlm.nih.gov/pubmed/28103578 http://dx.doi.org/10.18632/oncotarget.14704

Ejemplares similares

Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review
por: Kim, Hyeong Su, et al.
Publicado: (2018)

Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2018)

Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)

Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma
por: TAYLOR, CLAIRE, et al.
Publicado: (2012)

Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis
por: Kim, Hyeong Su, et al.
Publicado: (2019)

Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)

Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
por: McRonald, Fiona E, et al.
Publicado: (2009)

VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?
por: Stehle, Franziska, et al.
Publicado: (2015)

Loss of Von Hippel–Lindau (VHL) Tumor Suppressor Gene Function: VHL–HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)
por: Kim, Hyunho, et al.
Publicado: (2021)

Prognostic Impact of TTF-1 Expression in Non-Squamous Non-Small-Cell Lung Cancer: A Meta-Analysis
por: Kim, Jung Han, et al.
Publicado: (2018)

VHL mosaicism: the added value of multi-tissue analysis
por: Oldfield, Leslie E., et al.
Publicado: (2022)

Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
por: Zhang, Jin, et al.
Publicado: (2020)

KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review
por: Kim, Bum Jun, et al.
Publicado: (2016)

Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2018)

Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation
por: Moore, L E, et al.
Publicado: (2012)

Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma
por: Patard, J-J, et al.
Publicado: (2009)

VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in Clear Cell Renal Cell Carcinoma
por: Hu, Junhui, et al.
Publicado: (2023)

Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma
por: Koch, Christian A, et al.
Publicado: (2006)

Trichloroethylene exposure and somatic mutations of the VHL gene in patients with Renal Cell Carcinoma
por: Charbotel, Barbara, et al.
Publicado: (2007)

Biostatistics of VHL-Gene Transfection in the Health Informatics Analysis of Renal Cell Carcinoma
por: Gong, Yunxiang, et al.
Publicado: (2022)

Delayed Cardiac Metastasis from Renal Cell Carcinoma Caused by VHL Mutation
por: Sudduth, Christopher L., et al.
Publicado: (2023)

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
por: Hu, Junhui, et al.
Publicado: (2023)

Entrectinib Induces Apoptosis and Inhibits the Epithelial–Mesenchymal Transition in Gastric Cancer with NTRK Overexpression
por: Sohn, Sung-Hwa, et al.
Publicado: (2021)

Prognostic nutritional index as a prognostic factor for renal cell carcinoma: A systematic review and meta-analysis
por: Shim, Sung Ryul, et al.
Publicado: (2022)

MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Tepotinib Inhibits the Epithelial–Mesenchymal Transition and Tumor Growth of Gastric Cancers by Increasing GSK3β, E-Cadherin, and Mucin 5AC and 6 Levels
por: Sohn, Sung-Hwa, et al.
Publicado: (2020)

TRK inhibitors block NFKB and induce NRF2 in TRK fusion-positive colon cancer
por: Sohn, Sung-Hwa, et al.
Publicado: (2021)

The VHL-dependent regulation of microRNAs in renal cancer
por: Neal, Calida S, et al.
Publicado: (2010)

VHL-deficiency leads to reductive stress in renal cells
por: Vellama, Hans, et al.
Publicado: (2023)

Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma
por: Gemmill, R M, et al.
Publicado: (2005)

AB174. VHL protein: a new therapeutic target of renal cell carcinoma
por: Wang, Jiangyi, et al.
Publicado: (2015)

CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma
por: Schokrpur, Shiruyeh, et al.
Publicado: (2016)

Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma
por: Xiao-fen, Wu, et al.
Publicado: (2016)

Cytosine 5-hydroxymethylation regulates VHL gene expression in renal clear cell carcinoma
por: Ma, En-Guang, et al.
Publicado: (2017)

RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancer
por: Sohn, Sung-Hwa, et al.
Publicado: (2021)

Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
por: Cho, Yoon Ah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mg0bpv4fj62tmba6f1up3ftkr4